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ADVANCED PERKINSUS MARINUS INFECTIONS IN CRASSOSTREA ARIAKENSIS
MAINTAINED UNDER LABORATORY CONDITIONS
JESSICA A. MOSS, EUGENE M. BURRESON AND KIMBERLY S. REECE*
Virginia Institute of Marine Science, The College of William and Mary, Gloucester Point, VA 23062
ABSTRACT The Suminoe oyster, Crassostrea ariakensis, has been under investigation since the early 1990s for potential use in
restoring the commercial harvest or for aquaculture of oysters in the Chesapeake Bay, USA. Initial studies focusing on C. ariakensis
documented a significant level of tolerance to the protozoan parasite Perkinsus marinus, a pathogen found in almost all reaches of the
Bay and widely acknowledged as one of the main reasons for the decline in the eastern oyster, Crassostrea virginica, harvest since the
late 1980s. Crassostrea ariakensis was demonstrated to acquire P. marinus, however infection intensities, as measured using Ray’s
thioglycollate medium assay indices, generally were found to be light. As part of a series of experiments to study potential impacts on
the Chesapeake Bay region of pathogens found in C. ariakensis in Asia, a challenge experiment was conducted to study the
pathogenicity of Perkinsus olseni to C. ariakensis. During this study, we observed the acquisition of moderate and heavy infection
intensities of P. marinus in triploid C. ariakensis oysters being maintained in the laboratory. Results suggest that there may be some
risk of mortality from P. marinus if C. ariakensis is held under stressful conditions at least in hatchery or laboratory settings.
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olseni was found during a recent survey of C. ariakensis populations in Asia (Moss & Reece 2005). Prior to the start of the challenge experiment, C. ariakensis were initially determined to be
Perkinsus sp.-free, based on molecular diagnostics using PCR (Casas et al. 2002). The oysters acquired detectable levels of the
parasite, however, after being held for about 8 weeks in the laboratory aquaria. We used the infected oysters in our challenge study,
despite baseline P. marinus infection prevalence, to examine the
potential for C. ariakensis oysters to become coinfected with multiple Perkinsus species. We report here our observations regarding
the P. marinus infection levels observed in C. ariakensis during
this challenge experiment.

INTRODUCTION

The eastern oyster, Crassostrea virginica (Gmelin, 1791), an
integral part of the economy and ecology of the Chesapeake Bay,
has been in a severe state of decline in recent decades. Two pathogens, Haplosporidium nelsoni (Haskin, Stauber & Mackin, 1966)
and Perkinsus marinus (Mackin, Owen & Collier, 1950), the parasites responsible for the diseases known as MSX and dermo respectively, have contributed significantly to the decimation of the
oyster populations in Chesapeake Bay since the 1950s (Sindermann 1990).
The decline in oyster production in Virginia led to the formation of a number of panels in the early 1990s to make recommendations on restoring oyster populations. One option currently being
seriously considered is the introduction and use of a nonnative
oyster in Chesapeake Bay. A Virginia Institute of Marine Science
(VIMS) study conducted in 1996 focusing on the Pacific oyster,
Crassostrea gigas (Thunberg, 1793), documented lower disease
susceptibility in C. gigas than in the native eastern oyster, C.
virginica; however, growth rates of the Pacific oyster were equal
to or inferior to the native oyster in the Chesapeake Bay (Calvo et
al. 1999). A 1998 field-based study on another Asian oyster, the
Suminoe oyster, Crassostrea ariakensis (Fujita, 1913), documented rapid growth and survival in that species, as compared with
C. virginica, even when endemic diseases were prevalent (Calvo et
al. 2001). Although initial baseline samples of C. ariakensis in that
study revealed a 12% prevalence of P. marinus, all subsequent
samples collected after field deployment showed C. virginica with
higher P. marinus prevalence than C. ariakensis. Additionally,
Ray fluid thioglycollate medium (RFTM) (Ray 1952) diagnoses
showed several heavy P. marinus infections in C. virginica, however, only light infections were observed in C. ariakensis (Calvo et
al. 2001).
In this report we describe the first account of moderate to heavy
P. marinus infections in C. ariakensis. The oysters in this study
were held in laboratory aquaria at VIMS during a challenge experiment conducted to examine the potential pathogenicity of Perkinsus olseni Lester and Davis, 1981, to C. ariakensis, because P.

MATERIALS AND METHODS
Experimental Design

On January 24, 2005, 120 market sized (∼75 mm shell height)
triploid C. ariakensis were received from the Aquaculture Genetics
and Breeding Technology Center hatchery at VIMS. The animals
were held for 4 days inside a plastic mesh bag in a holding tank
prior to bringing them into the laboratory aquaria. The holding
tank was not covered and there was flow-through of nonfiltered
York River water of approximately 9°C and 16 ppt salinity. On
removal from the holding tank, 20 C. ariakensis were immediately
sacrificed, and gill and mantle tissues were excised aseptically
from each animal for DNA extraction. Genomic DNA of each
oyster was used in a PCR-based molecular diagnostic assay (Casas
et al. 2002) to examine the animals for the presence of DNA from
Perkinsus spp. parasites. The animals were subsequently held for
59 days in 10-gallon glass aquaria that were maintained at 20°C
and 25 ppt salinity at a density of approximately 25 oysters per
tank and were fed 0.1 g oyster−1 algal food daily (Reed Mariculture, San Jose, CA). At the end of 59 days, on March 24, 2005, five
C. ariakensis were sacrificed and gill and mantle were excised
aseptically from each animal to be used in Perkinsus spp. screening by PCR assays as described later.
On March 28, 2005, the remaining C. ariakensis (n ⳱ 60) were
used in a challenge experiment designed to evaluate the pathogenicity of P. olseni to C. ariakensis. Twenty C. ariakensis received
single pallial cavity injections of 100 L of 25 ppt sterile artificial
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seawater (SASW) through a notch in the shell, and 40 animals
were inoculated with 105 log phase cultured P. olseni cells per
gram body weight in a 100-L volume. The clonal P. olseni culture isolated from a Japanese Venerupis philippinarum (Adams
and Reeve, 1850) clam was obtained from Mr. Chris Dungan,
Maryland DNR Cooperative Oxford Laboratory, Oxford Maryland, (ATCC PRA-181). Thirty additional untreated, control C.
ariakensis were neither notched nor inoculated, but held in separate aquaria and otherwise maintained and fed in the same manner
as the experimental animals for the duration of the experiment.
Those C. ariakensis inoculated with 25 ppt SASW were maintained in one 10-gallon aquarium, and those inoculated with
P. olseni were split evenly between two aquaria. All aquaria were
identical and each tank was covered with a plexiglass lid.
All aquaria environments were maintained at 20°C to 22°C and
contained 25 ppt aerated, 1-m filtered York River water, two
thirds of which was removed each week and replaced with an
equal volume of clean, 25 ppt, 1-m filtered York River water.
Animals were fed daily a single dose of approximately 0.1 g oyster−1 algal feed (Reed Mariculture).
Aquaria were checked daily for oyster mortalities, and moribund animals were removed. The cumulative mortality was calculated for each sample as the sum of the mortalities that occurred
during the course of the experiment, which started 59 days after the
C. ariakensis were brought into the aquaria, divided by the number
of live animals at the start of the experiment. When moribund
animals were discovered, if adequate undegraded tissues remained
they were processed for analysis. Gill and mantle tissues were
removed with a portion preserved in 95% ethanol for DNA extraction and molecular diagnostics and gill, mantle and rectal tissues were processed for Ray fluid thioglycollate medium (RFTM)
assay (Ray 1952). After 27°C incubation for 5–6 days in RFTM,
tissues were removed from the culture tubes, macerated on microscope slides and stained with Lugol iodine. Stained, cover-slipped
tissue preparations were examined under a light microscope and
Perkinsus sp. tissue burdens were enumerated on a scale from rare
(R) to very heavy (VH) based on the categories of Ray (1952,
1954). Visceral mass tissue sections were preserved in Davidson’s
solution for histological analysis (Shaw & Battle 1957).
Experimental Sampling

Because of space constraints in the laboratory, the untreated C.
ariakensis that were remaining after 37 days were sacrificed and
tissues were taken for DNA, RFTM and histological analysis of
disease status as described earlier. For those tanks in which C.
ariakensis were inoculated with either 25 ppt SASW (one tank) or
with P. olseni (two tanks), two randomly chosen oysters from each
tank were removed and sacrificed for disease diagnosis on days 21,
44 and 59 postinoculation. The challenge experiment was terminated on day 72 and all remaining animals were sacrificed and
tissues preserved as mentioned earlier for DNA, RFTM and histological analysis.
Nucleic Acid Extraction

Genomic DNA was extracted from the excised mantle and gill
tissue snips, using a DNeasy Tissue Kit (Qiagen Inc., Valencia,
CA), following manufacturer’s protocols, except that DNA was
eluted in a single 200-L volume of elution buffer after a 10 min
incubation at room temperature (approximately 20°C).
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SSU Genes

To assure that PCR amplifiable DNA was present in all extracted samples, genomic DNAs were tested using universal small
subunit (SSU) ribosomal RNA gene primers 16S-A (5⬘ CCG AAT
TCG TCG ACA ACC TGG TTG ATC CTG CCA GT 3⬘) and
16S-B (5⬘ GGA TCC AAG CTT GAT CCT TCT GCA GGT TCA
CCT AC 3⬘) (modified from Medlin et al. 1988) with an expected
amplification product of approximately 1,800 bp. Each 25-L reaction contained 20 mM Tris-HCl (pH8.4), 50 mM KCl, 0.75 mM
MgCl2, 0.1 mM of each dNTP, 0.5 M each primer, 0.0125 U
L−1 Taq polymerase, 0.2 mg mL−1 BSA and 0.5 L genomic
DNA (∼10–50 ng total). Amplifications were performed with an
initial denaturation of 94°C for 4 min, followed by 35 cycles at
94°C for 30 sec, 45°C for 30 sec, 65°C for 2 min, with a final
elongation of 65°C for 2 min. After amplification, 3 L of PCR
product were analyzed by agarose gel electrophoresis (2%), stained
with ethidium bromide and visualized under UV light. Images
were recorded with an Alpha Innotech FlourChem (SanLeandro,
CA) imaging system.
Genus-specific Perkinsus sp. PCR Assay

Screening for Perkinsus sp. DNA was performed using Perkinsus genus-specific primers, PerkITS-85 (5⬘ CCG CTT TGT TTG
GAT CCC 3⬘) and PerkITS-750 (5⬘ ACA TCA GGC CTC TAA
TGA TG 3⬘) (Casas et al. 2002) that target the internal transcribed
spacer (ITS) region of the ribosomal RNA gene complex. Each
PCR reaction contained the following: PCR buffer at a concentration of 20 mM Tris-HCl (pH8.4), 50 mM KCl, 1.5 mM MgCl2, 0.2
mM of each dNTP each primer at 0.1 M, 0.025 U L-1 Taq
polymerase, 0.05 mg mL−1 BSA and 0.5 L genomic DNA (∼10–
50 ng total). Amplifications were performed with an initial denaturation of 95°C for 4 min followed by 40 cycles of 95°C for 1
min, 53°C for 1 min, 65°C for 3 min, with a final elongation of
65°C for 5 min. After amplification, 4 L of PCR product were
analyzed as described earlier.
Perkinsus Species-specific Assays

Identification of the Perkinsus species that was infecting animals shown to have positive amplification products with the Perkinsus genus-specific assay was accomplished through the use of
P. marinus and P. olseni species-specific PCR assays. Perkinsus
marinus-specific primers PmarITS-70F (5⬘ CCT TTG YTW GAG
WGT TGC CAG ATG 3⬘) and PmarITS-600R (5⬘ CGA GTT TGC
GAG TAC CTC KAG AG 3⬘) (Audemard et al. 2004) and P.
olseni-specific primers designed for this study Pols-140F (5⬘ GAC
CGC CTT AAC GGG CCG TGT T 3⬘) and PolsITS-600R (5⬘
GGR CTT GCG AGC ATC CAA AG 3⬘) were used in separate
25-L reactions. PCR reactions for the P. marinus ITS region
contained the following: PCR buffer at a concentration of 20 mM
Tris-HCl (pH8.4), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM each
dNTP, each primer at 0.1 M, 0.025 U L−1 Taq polymerase, 0.05
mg mL−1 BSA and 0.5 L genomic DNA (∼10–50 ng). Amplifications were performed with an initial denaturation of 95°C for 4
min followed by 40 cycles of 94°C for 1 min, 57°C for 1 min, 65°C
for 3 min, with a final elongation of 65°C for 10 min. PCR reactions for the P. olseni ITS region contained the following: PCR
buffer at a concentration of 20 mM Tris-HCl (pH8.4), 50 mM KCl,
1.5 mM MgCl2, 0.2 mM each dNTP, each primer at 0.1M, 0.025
U L−1 Taq polymerase, 0.05 mg mL−1 BSA and 0.5 L genomic
DNA (∼10–50 ng). Thermocycling parameters were as follows: an
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initial denaturation of 95°C for 4 min followed by 40 cycles of:
94°C for 1 min, 62°C for 1 min, 65°C for 3 min, all followed by
a final elongation step of 65°C for 10 min. After amplification, for
each species-specific reaction, 4 L of PCR product were analyzed
as described earlier.
Specificity of P. olseni primers was tested against P. marinus
and Perkinsus chesapeaki McLaughlin, Tall, Shaheen, Elsayed and
Faisal 2000, DNAs. In addition, amplification products from positive P. olseni-specific reactions were sequenced. PCR products
were cloned into the plasmid pCR4-TOPO and transformed into E.
coli using a TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA)
following the manufacturer’s protocols. Transformed bacterial
colonies were picked from agar plates using a sterile wooden
toothpick and were inoculated into 10 L of sterile water in 200
L plastic strip tubes. Inoculated water samples were boiled for 4
min at 94°C and 0.5 L of the boiled preparation was used in an
M13 PCR reaction using the forward and reverse primers supplied
in the cloning kit. Each 25 L reaction contained the following: 20
mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM
each dNTP each primer at 1M, 0.25 U L−1 Taq polymerase, and
0.2 mg mL−1 BSA. Thermocycling parameters were as follows: an
initial denaturation at 94°C for 2 min, followed by 30 cycles of
94°C for 30 sec, 54°C for 30 sec and 72°C for 1 min, followed by
a final elongation at 72°C for 5 min. Following amplification using
the M13 primer pairs, 3 L of each PCR product were analyzed as
mentioned earlier. Prior to sequencing, PCR products from clones
containing the correct insert size were treated with shrimp alkaline
phosphatase (SAP) and exonuclease I (Exo I) (Amersham Biosciences, Piscataway, NJ), to degrade nucleotides and singlestranded DNA (primers) remaining after PCR. Five micro liters of
the M13 PCR product were combined with 0.5 units of SAP and
5.0 units of Exo I, and incubated at 37°C for 30 min, 80°C for 15
min, and 15°C for at least 5 s. Clean PCR products from plasmid
inserts were sequenced bidirectionally using the Big Dye Terminator kit (Applied Biosystems, Norwalk, CT) with M13 sequencing primers, and using 5-L reactions with 0.125 times the concentration of Big Dye reagent specified in the manufacturer’s protocols. Each 5 L reaction contained 0.0625 L of Big Dye,
0.96875 L of 5× buffer, 1.6 pmol of each primer, and 10 ng of clean
PCR product. Thermocycling parameters were as follow: 25 cycles
of 96°C for 1 min, 96°C for 10 sec, 50°C for 5 sec, 60°C for 4 min,
followed by a final incubation at 4°C until the sequencing reaction products were precipitated using the ethanol/sodium acetate precipitation method (ABI User Bulletin, April 11, 2002). Precipitated
sequencing reaction products were resuspended in 20 L of Hi-Di
formamide (Applied Biosystems) and 10 L of each were electrophoretically separated on an ABI 3100 Prism Genetic Analyzer.
RFLP

For further confirmation of the presence of P. marinus or P.
olseni DNA, and to further verify the specificity of the Perkinsus
species-specific primer sets, genus-specific PerkITS-85/750 amplification products were digested with Mbo I restriction endonuclease (New England Biolabs, Beverly, MA). Based on analyzing
published and unpublished sequence data of all known Perkinsus
species, this enzyme will cut the approximately 760 bp ITS fragment of P. marinus DNA that is generated in the genus-specific
assay to yield a 3-fragment digestion profile unique to this species.
The fragments should be approximately 17,226 and 264 bp in
length. For P. olseni, Mbo I should cut the ITS region fragment to
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yield a 4-fragment digestion profile with fragment lengths of approximately 64, 85, 251 and 262 bp in length. Each 10-Ldigestion reaction contained 5 L of PCR product, 8.2 L of
sterile distilled water, 1.5 L of 10X NEB buffer 3, and 0.3 L of
restriction enzyme. As controls, separate oyster genomic DNA
samples, determined previously to be infected with P. olseni and P.
marinus, and plasmid-purified P. chesapeaki ITS DNA was first
amplified with the Perkinsus genus-specific primers, Perk-ITS85/
750, as described above and then digested with Mbo I restriction
endonuclease. We chose to use only P. marinus, P. olseni and P.
chesapeaki DNAs as controls, because these were the Perkinsus
species, that we expected might be present in our samples. Perkinsus olseni was being used in the experiment and P. marinus and
P. chesapeaki are common to Chesapeake Bay and potentially
their DNAs could have contaminated the 1-m filtered York River
water, although this was not likely. PCR products were digested at
37°C for 6 h and 10 L of the digested PCR product was electrophoresed on a 3% agarose gel that was 1.5% agarose and 1.5%
low melt agarose (Fisher Scientific, Raleigh, NC), stained with
ethidium bromide and visualized under UV light. Images were
recorded with an Alpha Innotech FlourChem (SanLeandro, CA)
imaging system.
Histological Analysis

Tissues preserved for histological analysis in Davidson’s solution (Shaw & Battle 1957) were dehydrated in a series of ethanol
baths, infiltrated with paraffin and embedded in paraffin blocks
prior to sectioning. Sections of 5-m thickness were stained with
Harris-hematoxylin and eosin. Histological sections of infected
oysters were examined using light microscopy to visualize Perkinsus sp. parasite cells in situ.
In-situ Hybridization

Representative tissue sections from a few of the C. ariakensis
oysters determined to have P. marinus or mixed infections of both
P. marinus and P. olseni by species-specific PCR were evaluated by
in situ hybridization (ISH). A genus-specific 5⬘ end digoxigeninlabeled Perkinsus probe (Elston et al. 2004) was used to specifically target SSU rRNA sequences. Perkinsus species-specific
probes, PmarLSU-181DIG (5⬘-GACAACGGCGAACGACTC-3⬘),
specific to P. marinus, and PolsLSU-464DIG (5⬘-CTCACAAGTGCCAAACAACTG-3⬘), specific to P. olseni, were designed by
locating unique regions in aligned available Perkinsus species
LSU rRNA gene sequences. Digoxigenin-labeled oligos were obtained from Operon Biotechnologies, Inc. (Huntsville, AL). The
protocol followed for ISH was that previously published (Stokes &
Burreson, 1995) with the modifications published by Elston et al.
(2004). Pronase at a final concentration of 125 g mL−1 was used
for permeabilization during a 30-min incubation, and a probe
concentration of 7 ng L−1 was used for hybridization. The
species-specific probes were tested for specificity with numerous
Perkinsus sp.-infected reference tissues, including P. marinus in
C. virginica, P. chesapeaki in Mya arenaria Linnaeus, 1758 and
P. olseni in Haliotis laevigata Donovan, 1808. Controls for each
Perkinsus species-specific probe were tested identically except
that they received hybridization buffer lacking probe during the
hybridization step.
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TABLE 1.
RFTM ranking and PCR-based Perkinsus genus-specific assay screening results of the challenge study oysters that were notched and
inoculated with either SASW or cultured P. olseni cells and sampled from the experimental aquaria on days 44, 59 and 72.
Day 44 (n = 2)
SASW
RFTM Ranking
None (N)
Rare (R)
Very Light (VL)
Light (L)
Light/Moderate (LM)
Moderate (M)
Moderate/Heavy (MH)
Heavy (H)
Very Heavy (VH)

Day 44 (n = 4)
P. olseni

#
RFTM

# PCR
Pos

#
RFTM

# PCR
Pos

2

1

2
1
1

Day 59 (n = 2)
SASW
#
RFTM

Day 72 (n = 6)
SASW

Day 72 (n = 15)
P. olseni

#
RFTM

# PCR
Pos

#
RFTM

# PCR
Pos

#
RFTM

# PCR
Pos

1

1

1

3
3

3
3

1
1

2

2

1
1
2*
6
1

1
1
2
6
1

1

1
1
3

1
3

1
1

# PCR
Pos

Day 59 (n = 4)
P. olseni

1
1

* Species-specific PCR assays indicated that one of these individuals, as well as one P. olseni-inoculated individual collected on day 21 (data not shown),
contained DNA from both P. marinus and P. olseni. Only P. marinus DNA was detected in all other individuals.
RESULTS
Genus-specific PCR and RFTM Assay Results

All tissue samples used for DNA extraction yielded high quality genomic DNA as indicated by strong 1,800 bp amplification
products that were clearly visible by UV illumination of agarose
gels following PCR with the SSU rRNA gene universal primers.
Perkinsus genus-specific PCR-based diagnostic screening of an
initial baseline subset of 20 C. ariakensis sacrificed on January 24,
2005 showed that all animals were free of Perkinsus DNA. After
being held in the laboratory aquaria for 59 days, prior to inoculation, five C. ariakensis were sacrificed and genus-specific PCR
screening indicated a 100% prevalence of Perkinsus sp. DNA.
RFTM and Perkinsus genus-specific PCR screening results for
the C. ariakensis that were inoculated with SASW or P. olseni
cells are shown in Table 1. RFTM data were not collected during
the first day of subsampling (Day 21), however the PCR screening
indicated the presence of Perkinsus sp. DNA in both oysters
sampled from those inoculated with SASW and in three of the four
oysters sampled from the P. olseni injections. There were no Perkinsus cells observed by RFTM assays in the day 44 SASW
sample, although Perkinsus sp. DNA was found by the PCR assay
in one of the two oysters sampled. Very light-light RFTM rankings
were found for two of the four P. olseni-inoculated oysters
sampled on day 44 and three of the four were positive in the
Perkinsus genus-specific PCR assay. On day 59 both of the
SASW-inoculated oysters sampled had moderate-moderate/heavy
Perkinsus sp. tissue burdens and Perkinsus sp. DNA was found in
both by the PCR assay. Three of the four P. olseni-inoculated
oysters that were sampled on day 59 had light-moderate infections
as indicated by the RFTM assay and Perkinsus DNA was detected
in all four of the oysters. On day 72, when the experiment was
terminated, six SASW- and 15 P. olseni-treated oysters remained
and were sacrificed. Perkinsus DNA was found by the PCR assay
in all of the oysters remaining from the two treatment groups
(Table 1). Perkinsus sp. cells were not detected, however, by the
RFTM assay in three of the SASW-inoculated or in one of the P.
olseni-inoculated oysters. The other three remaining SASWinoculated oysters had rare RFTM rankings. Rare-light/moderate

tissue burdens were found in nine P. olseni-inoculated oysters at
the end of the experiment and four P. olseni-inoculated oysters had
heavy-very heavy infections as indicated by the RFTM assay.
RFTM and P. marinus PCR assay results for the 29 untreated
C. ariakensis that were still alive and were sacrificed on day 37 of
the challenge experiment are shown in Table 2. Eighteen of these
oysters were ranked as having rare to light Perkinsus sp. tissue
burdens, two were ranked as light/moderate and two as moderatemoderate/heavy tissue burdens. Seven had no observable Perkinsus sp. cells in the RFTM assay, however five of these were
positive in the PCR assay. Perkinsus marinus DNA, as indicated
by the PCR assay, was found in 23 of these 29 untreated oysters
(Table 2), with no DNA detected in three of the oysters with a rare
RFTM ranking and in one with a light infection as indicated by the
RFTM assay.
Mortality Data

Mortality was observed in untreated oysters and in those injected with either SASW or P. olseni (Table 3). For the untreated
C. ariakensis, two died during the 37 day period that they were
TABLE 2.
RFTM ranking and PCR-based P. marinus assay screening results
of control untreated C. ariakensis (unnotched and uninoculated) on
day 37 of the challenge study.
Day 37 (n = 29)
RFTM Ranking

# Individuals

# P. marinus PCR+

None (N)
Rare (R)
Very Light (VL)
Light (L)
Light/Moderate (LM)
Moderate (M)
Moderate/Heavy (MH)
Heavy (H)
Very Heavy (VH)

7
7
3
8
2
1
1

5
4
3
7
2
1
1

(Note: P. olseni DNA was not detected in any of these oysters.)
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TABLE 3.
Daily observed C. ariakensis mortalities during the course of the
challenge experiment.
Day

Untreated

2
11
37
43
49
53
55
58
59
64
66
72

1
1

25 ppt SASW

Perkinsus olseni

4

1
1
1
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ITS region DNA, were amplified in the Perkinsus genus-specific
assay and were digested with Mbo I restriction endonuclease. Results confirmed that P. marinus ITS region DNA has a unique
digestion profile when digested with Mbo I and the observed fragment sizes of approximately 17 bp, 226 bp and 264 bp were
consistent with the fragment sizes expected for P. marinus.
Histology

1
na*
na
na
na
na
na
na
na
na

IN

1
1
1
4
1
2
1
6

Ten animals shown by PCR to have Perkinsus sp. DNA, and
whose tissues showed light to very heavy RFTM rankings were
chosen for further histological examination. A tissue section from
one animal with a very heavy RFTM ranking that had died during
the experiment showed gross lesions (Fig. 1A) and observable
parasite cells when stained with Harris-hemotoxylin and eosin
(Fig. 1B). Parasite cells were numerous and observed systemically

* na ⳱ not applicable because the oysters from the untreated tank were
sacrificed on day 37.
Column headings indicate the sample treatments.

held in the aquaria. For the SASW treatment and the P. olseni
treatment, cumulative mortality after 72 days was 40.0% and
46.2%, respectively. Of the 27 dead C. ariakensis removed from
the untreated tank and the experimental aquaria during the course
of the experiment, it was possible to conduct RFTM analysis on 11
oysters and PCR analysis on 22. All tissues taken from dead C.
ariakensis were PCR positive for Perkinsus sp. DNA. Of these 11
oysters examined by RFTM, 2 had none, or rarely observable
Perkinsus sp. cells, 2 had very light or light tissue burdens, 1 had
a light/moderate tissue burden and 6 had moderate to heavy tissue
burdens of Perkinsus sp. cells.
Species-specific PCR Screening for Perkinsus marinus and
Perkinsus olseni

DNAs from all oysters shown to be PCR positive with the
Perkinsus genus-specific assay were analyzed using both P. marinus-specific and P. olseni-specific primers. Because the P. olseni
primers were new for this study, specificity was tested against P.
marinus and P. chesapeaki DNAs. The P. olseni primers did not
amplify DNA from these other Perkinsus species. Sequencing of
amplification products further confirmed the specificity as sequences of amplification products from all positive P. olsenispecific reactions matched those of GenBank deposited P. olseni
(P. atlanticus) sequences. The five C. ariakensis taken as a baseline sample immediately prior to the start of the study, and all
untreated oysters had only P. marinus DNA. In addition, all but
two of the C. ariakensis that were SASW- or P. olseni-inoculated
and that were Perkinsus sp. positive with the genus-specific primers, were positive for only P. marinus DNA. Two oysters that were
inoculated with P. olseni at the start of the challenge and were
sampled on days 21 and 72 were positive for both P. marinus and
for P. olseni DNA. Tissue from all dead oysters collected from
either the experimental or untreated aquaria were found to be
PCR-positive for P. marinus only.
RFLP Results

The P. olseni and P. marinus positive control DNA isolated
from cultured cells, and plasmid-purified Perkinsus chesapeaki

Figure 1. H&E-stained histological section of Perkinsus marinus lesions in the gonad of Crassostrea ariakensis. (A) Low power photomicrograph showing the extent of the lesions (arrows) in the vicinity of
the gonoduct (g). Square represents the area shown in B. (B) Higher
magnification in the vicinity of a gonoduct (g) showing P. marinus cells
(arrows) in the lesions.
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throughout the visceral mass. Obvious lesions caused by Perkinsus
sp. infection were not observed by histology in tissue sections
taken from animals with light or moderate Perkinsus sp. tissue
burdens as determined by the RFTM assays.
ISH Assay Results

In-situ hybridization probes designed to target the LSU rRNA
genes of P. marinus or P. olseni exhibited specificity for the targeted Perkinsus species. In the specificity tests, the P. marinus
probe hybridized only to the Perkinsus cells in the sample of P.
marinus in C. virginica and the P. olseni probe hybridized to
Perkinsus sp. cells in the control sample of P. olseni in Haliotis
laevigata. The probes did not cross-react with nontargeted Perkinsus species or host tissues in other control samples. Figure 2A to
D shows four consecutive sections from the heavily infected oyster
shown in Figure 1. Figure 2A is an H&E-stained section. Figure
2B shows positive in-situ hybridization with the PmarDIGLSU181 probe to Perkinsus sp. cells indicating that the lesions were
caused by P. marinus. The P. marinus-specific probe bound to
cells throughout the digestive epithelium, gonads and gonoducts.
In situ hybridization reactions conducted without probe (Fig. 2C),
or with the PolsDIGLSU-464 probe (Fig. 2D), produced no signal
in host tissues of this oyster. The PolsDIGLSU-464 probe was also
tested against two individuals that were inoculated with P. olseni
and found to harbor both P. marinus and P. olseni DNA by the
PCR assays. The P. marinus probe hybridized to Perkinsus sp.
cells in the dually infected oysters, however, no binding of the P.
olseni probe was observed, suggesting that infections by P. olseni
were extremely light, or that only P. olseni DNA was present and
not viable cells.

ET AL.

DISCUSSION

Initial screening using a PCR-based diagnostic method on a
sample of the triploid C. ariakensis oysters that were obtained for
the challenge study suggested that they did not harbor P. marinus.
A small sample (n ⳱ 5) of these oysters screened 59 days later,
however, had 100% P. marinus DNA prevalence as indicated by
the P. marinus- specific PCR assay. We suggest that the C. ariakensis oysters either acquired a small number of P. marinus cells
that were not numerous enough to be detected by our initial PCR
assay of gill/mantle tissue, while in the VIMS hatchery before
collection for this experiment, or while being held in unfiltered
York River water for 4 days prior to being brought into the aquaria
where they were subsequently held only in filtered York River
water. The P. marinus proliferated to PCR detectable levels after
59 days in aquaria with disease developing and mortality subsequently occurring in not only those oyster groups that had been
subjected to notching and inoculation with either SASW or P.
olseni for the challenge study, but also in the control group of
unnotched and untreated oysters that were simply held for an additional 37 days during the challenge experiment.
RFTM and PCR assay results for the C. ariakensis initially
inoculated with either 25 ppt SASW or cultured P. olseni cells for
the challenge study revealed a progression of P. marinus infection
in the oyster tissues. Sampling and subsequent PCR-based screening of both the 25 SASW and P. olseni-inoculated oysters on
Days 21 and 44 indicated that P. marinus DNA was found in
83.3% and 66.7% of the oysters, respectively. We believe that the
apparent decrease in P. marinus prevalence on day 44 reflects
sampling error related to the small sample sizes (n ⳱ 6) assayed
to determine PCR-based Perkinsus sp. prevalence at each time

Figure 2. Perkinsus marinus in Crassostrea ariakensis. (A) H&E-stained histological section in the vicinity of a gonoduct (g) showing Perkinsus
marinus lesions (arrows). (B) In situ hybridization with the P. marinus-specific probe, Pmar181LSUDIG, illustrating strong binding to the
Perkinsus sp. cells (arrows). (C) No probe negative control showing no binding to the C. ariakensis tissue. (D) In situ hybridization with the P.
olseni-specific probe, Pols464LSUDIG, illustrating no binding to the Perkinsus sp. cells.
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point. Although P. olseni DNA was found in two of the P. olseniinoculated oysters (one each on days 21 and 72), there was an
increase in the observed PCR prevalence of P. marinus DNA to
100% in samples of all treated oysters collected on days 59 and 72.
Likewise, as determined by RFTM assays, the tissue burdens for
the two positive individuals were light in the P. olseni-treated
oysters collected on day 44 of the experiment. However, among
samples of these same oyster groups that were collected on days 59
and 72, not only light infections, but also moderate to very heavy
tissue burdens were observed. Interestingly, disease progression in
those C. ariakensis not notched or inoculated, mimicked that seen
in the manipulated experimental oysters based on the RFTM-based
tissue burdens. By day 37 when the control oysters were sacrificed,
the observed Perkinsus sp. tissue burdens ranged from light to
moderate/heavy.
During the course of the experiment, there were many instances
where dead oysters were discovered in the various treatment
groups, with little or no tissue available for either PCR or RFTM
analysis. It is important to note, however, that of the 1 dead oysters
with available tissue, more than half (55%) had moderate to heavy
tissue burdens.
Prevalence and intensity of P. marinus infections in C. virginica oysters are closely linked to temperature and salinity, and
the rate of infection in the natural environment is believed to be
proportional to the number of waterborne infective cells (Andrews
& Hewatt 1957, Chu et al. 1994). Warm water temperatures, 20°C
to 25°C, and high salinity >15 ppt, have been shown to correlate
with times of maximal proliferation of parasite cells, as well as
highest incidences of infection in oysters (Andrews & Hewatt
1957, Chu et al. 1994). Mortality of infected oyster hosts depends
on the level of infection, with an apparent dose of between 10 and
100 cells adequate to establish infection (Chu 1996). Because of
the effects of salinity and temperature on the parasite, the infections caused by P. marinus are seasonal in the Chesapeake Bay,
with maximum parasite prevalence recorded in late summer and
minimum prevalence observed during the winter months (Burreson & Ragone Calvo 1996). York River water conditions during
the time that the oysters were in the holding tank were approximately 9°C and 16 ppt salinity. Environmental conditions of the
York River were not likely favorable for P. marinus proliferation
at the start of these experiments; however, it has been shown that
parasite cells can remain viable in over wintering conditions of
temperatures as low as 4°C and a salinity of 4 ppt (Chu & Greene
1989, Ragone Calvo & Burreson 1994, Chu 1996). Therefore, we
cannot discount the possible presence of parasite cells in the York
River water during the holding period, when the oysters were in
unfiltered water. The experimental conditions under which the
oysters were held, 20°C and 25 ppt salinity, would have favored
the proliferation of P. marinus cells present in the oysters, accounting for the increase in infection prevalence observed after the
baseline sampling.
Cumulative mortalities were highest in those treatments where
oysters were subjected to the extra stress of notching and injection,
and the highest Perkinsus sp. tissue burdens were seen in dead C.
ariakensis. We may have observed higher cumulative mortalities
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in the untreated control oysters, as well, had they been held for a
longer time period. In C. virginica, digestive gland epithelia and
the stomach are often heavily colonized with P. marinus and damaged. As parasite proliferation increases to lethal levels, massive
tissue sloughing occurs, which eventually contributes to the death of
the animals (Mackin, 1951). In this study, tissue sections from a
moribund C. ariakensis with a very heavy RFTM ranking showed
dense, systemic P. marinus infection and the ISH assays confirmed
that all of the observable Perkinsus sp. cells were P. marinus. Collectively, the results presented here strongly suggest that P. marinus
was an important contributing factor to the death of these oysters.
Because P. olseni was found during a recent survey of C.
ariakensis populations in Asia (Moss & Reece 2005), this study
was initiated to examine the pathogenicity of P. olseni to C. ariakensis. At the termination of this experiment, however, PCR
based diagnostics suggested that a relatively low number of the P.
olseni-inoculated C. ariakensis (n ⳱ 2) harbored both P. marinus
and P. olseni DNA. This result may indicate that C. ariakensis are
not readily susceptible to P. olseni, or that virulence attenuation of
the parasite may have occurred during the culturing period prior to
the use of the parasite as inoculum. Virulence attenuation with
in-vitro cultured P. marinus cells has been documented (Ford et al.
2002). Recent studies, however, have demonstrated that cultured
cell virulence is enhanced by supplementing media with host oyster homogenate (MacIntyre et al. 2003, Earnhart et al. 2004) and
therefore, we plan to do homogenate supplementation of media for
Perkinsus sp. isolates used in future challenge studies.
Although little data on P. olseni pathogenicity was obtained
during this experiment, it provided valuable information regarding
the potential for advanced P. marinus infections to occur in C.
ariakensis. Prior field studies conducted in Chesapeake Bay have
indicated that although C. ariakensis is capable of acquiring P.
marinus infections (Calvo et al. 2001), there was no evidence that
C. ariakensis was susceptible to the advanced parasite infections
known to occur in C. virginica. We contend that the experimental
environmental conditions, under which the oysters were held for a
total of 5 months, combined with the stress of the unnatural aquaria
environment and experimental manipulation, may have promoted
the development of the intense P. marinus infections in C. ariakensis that were observed here. This study provides valuable information on potentially problematic disease issues including parasite
proliferation that can arise if P. marinus-infected C. ariakensis
encounter stress challenges in the wild or aquaculture environment, or if they are held in hatcheries or laboratories under stressful conditions.
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